Lantheus to Present at March 2026 Investor Conferences
Rhea-AI Summary
Lantheus (NASDAQ: LNTH) announced that Mary Anne Heino, Executive Chairperson and CEO, will present at two investor conferences in March 2026: TD Cowen 46th Annual Health Care Conference on March 3, 2026 at 11:10 a.m. ET and Leerink Global Healthcare Conference on March 10, 2026 at 8:00 a.m. ET.
Live webcasts will be accessible via the Investors section of the company's website, with replays available for at least 30 days following each presentation.
Positive
- None.
Negative
- None.
Details
News Market Reaction – LNTH
In the Feb 24 session, LNTH gained 0.26%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- TD Cowen conference date
- March 3, 2026
- TD Cowen 46th Annual Health Care Conference presentation
- TD Cowen presentation time
- 11:10 a.m. ET
- Scheduled time for LNTH presentation
- Leerink conference date
- March 10, 2026
- Leerink Global Healthcare Conference presentation
- Leerink presentation time
- 8:00 a.m. ET
- Scheduled time for LNTH presentation
- Webcast replay period
- at least 30 days
- Replay availability on company’s website
Historical Context
-
Scheduled Q4 and full-year 2025 earnings call and webcast announcement.
-
Completed sale of SPECT business to refocus on PET and radiopharmaceuticals.
-
Announced florbetaben F 18 data presentation at CTAD 2025 conference.
-
Reported Q3 2025 results, updated guidance, and multiple PDUFA dates.
-
Announced CEO retirement, interim leadership, and broader executive changes.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BEDFORD, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver better patient outcomes, today announced Mary Anne Heino, Executive Chairperson and Chief Executive Officer, will present at the following investor conferences.
- TD Cowen 46th Annual Health Care Conference
March 3, 2026 at 11:10 a.m. ET - Leerink Global Healthcare Conference
March 10, 2026 at 8:00 a.m. ET
To access the live webcast of the presentations, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcasts will be available on the Company’s website for at least 30 days following the live presentation.
About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Sweden, Switzerland, and the United Kingdom, Lantheus has been providing radiopharmaceutical solutions for 70 years. For more information, visit www.lantheus.com.
Contacts:
Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com
Melissa Downs
Executive Director, External Communications
646-975-2533
media@lantheus.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.